OSCILLATE - Phase 2 Trial of Alternating Osimertinib with Gefitinib in Patients with EGFR-T790M Mutation Positive Advanced NSCLC

Solomon, B; Kok, P; Livingstone, Ann; Yip, S; Brown, C; Dawson, S; Wong, S; Pavlakis, N; Stockler, M

File(s) under permanent embargo

OSCILLATE - Phase 2 Trial of Alternating Osimertinib with Gefitinib in Patients with EGFR-T790M Mutation Positive Advanced NSCLC

Version 2 2024-06-06, 05:21

Version 1 2023-03-24, 01:11

conference contribution

posted on 2024-06-06, 05:21 authored by B Solomon, P Kok, Ann LivingstoneAnn Livingstone, S Yip, C Brown, S Dawson, S Wong, N Pavlakis, M Stockler

OSCILLATE - Phase 2 Trial of Alternating Osimertinib with Gefitinib in Patients with EGFR-T790M Mutation Positive Advanced NSCLC

History

Volume

12

Pagination

S2143-S2143

ISSN

1556-0864

eISSN

1556-1380

Language

English

Author URL

https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000463860801717&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a045e4b2bb1f2b747c68c720ec8913b7

Publication classification

E3 Extract of paper

Title of proceedings

JOURNAL OF THORACIC ONCOLOGY

Issue

11

Publisher

ELSEVIER SCIENCE INC

Usage metrics

Keywords

Science & Technology Life Sciences & Biomedicine Oncology Respiratory System osimertinib T790M EGFR

Licence

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

File(s) under permanent embargo

OSCILLATE - Phase 2 Trial of Alternating Osimertinib with Gefitinib in Patients with EGFR-T790M Mutation Positive Advanced NSCLC

History

Volume

Pagination

ISSN

eISSN

Language

Author URL

Publication classification

Title of proceedings

Issue

Publisher

Usage metrics

Categories

Keywords

Licence

Exports